The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: A randomised controlled study

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  De Waal, Hanneke ^a   Stam, Cornelis J ^a   Lansbergen, Marieke M ^b   Wieggers, Rico L ^b   Kamphuis, Patrick J G H ^b   Scheltens, Philip ^a   Maestú, Fernando ^c   Van Straaten, Elisabeth C W ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Nutricia Nederland   (Netherlands)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAPHY; FEASIBILITY STUDY; FEMALE; FOOD; FUNCTIONAL BRAIN NETWORK; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTICENTER STUDY; NERVE CELL NETWORK; NEUROANATOMY; NEUROPSYCHOLOGICAL TEST; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SOUVENAID; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; THERAPY EFFECT; TREATMENT DURATION;

AGED; ALZHEIMER DISEASE; BRAIN; CHOLINE; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ELECTROENCEPHALOGRAPHY; FOLIC ACID; FOOD, FORMULATED; HUMANS; LIKELIHOOD FUNCTIONS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NERVE NET; PHOSPHOLIPIDS; REGRESSION ANALYSIS; SELENIUM; SYNAPSES; TREATMENT OUTCOME; URIDINE MONOPHOSPHATE; VITAMINS;

EID: 84900312887     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086558     Document Type: Article

References (54)

1. World Health Organization, Alzheimer's Disease International (2012) Dementia: a public health priority. Geneva; London.
2. Davies CA, Mann DM, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78: 151-164. (Pubitemid 17031709)
3. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, et al. (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A 89: 1671-1675.
4. van Spronsen M, Hoogenraad CC (2010) Synapse pathology in psychiatric and neurologic disease. Curr Neurol Neurosci Rep 10: 207-214.
5. Weintraub S, Wicklund AH, Salmon DP (2012) The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med 2: a006171.
6. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, et al. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9: 119-128.
7. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298: 789-791.
8. Bokde ALW, Ewers M, Hampel H (2009) Assessing neuronal networks: understanding Alzheimer's disease. Prog Neurobiol 89: 125-133.
9. Scheltens P, Kamphuis PJGH, Verhey FRJ, Olde Rikkert MGM, Wurtman RJ, et al. (2010) Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial. Alzheimers Dement 6: 1-10.e1.
10. de Wilde MC, Kamphuis PJGH, Sijben JWC, Scheltens P (2011) Utility of imaging for nutritional intervention studies in Alzheimer's disease. Eur J Pharmacol 668 Suppl 1: S59-S69.
11. Buzsáki G (2006) Rhythms of the brain. Oxford; New York: Oxford University Press.
12. Bassett DS, Bullmore ET (2009) Human brain networks in health and disease. Curr Opin Neurol 22: 340-347.
13. Jeong J (2004) EEG dynamics in patients with Alzheimer's disease. Clin Neurophysiol 115: 1490-1505.
14. Hubbard O, Sunde D, Goldensohn ES (1976) The EEG in centenarians. Electroencephalogr Clin Neurophysiol 40: 407-417.
15. Dierks T, Frölich L, Ihl R, Maurer K (1995) Correlation between cognitive brain function and electrical brain activity in dementia of Alzheimer type. J Neural Transm 99: 55-62.
16. van der Hiele K, Vein AA, Reijntjes RHAM, Westendorp RGJ, Bollen ELEM, et al. (2007) EEG correlates in the spectrum of cognitive decline. Clin Neurophysiol 118: 1931-1939. (Pubitemid 47187761)
17. Aertsen AM, Gerstein GL, Habib MK, Palm G (1989) Dynamics of neuronal firing correlation: modulation of ́effective connectivitý. J Neurophysiol 61: 900-917.
18. He Y, Chen Z, Gong G, Evans A (2009) Neuronal networks in Alzheimer's disease. Neuroscientist 15: 333-350.
19. Dunkin JJ, Osato S, Leuchter AF (1995) Relationships between EEG coherence and neuropsychological tests in dementia. Clin Electroencephalogr 26: 47-59.
20. Babiloni C, Ferri R, Binetti G, Cassarino A, Dal Forno G, et al. (2006) Frontoparietal coupling of brain rhythms in mild cognitive impairment: a multicentric EEG study. Brain Res Bull 69: 63-73. (Pubitemid 43185345)
21. Park YM, Che HJ, Im CH, Jung HT, Bae SM, et al. (2008) Decreased EEG synchronization and its correlation with symptom severity in Alzheimer's disease. Neurosci Res 62: 112-117.
22. Bullmore E, Sporns O (2009) Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 10: 186-198.
23. Stam CJ, van Straaten ECW (2012) The organization of physiological brain networks. Clin Neurophysiol 123: 1067-1087.
24. van Steen M (2010) Graph Theory and Complex Networks; An Introduction.
25. Watts DJ, Strogatz SH (1998) Collective dynamics of 'small-world' networks. Nature 393: 440-442. (Pubitemid 28292183)
26. Stam CJ (2004) Functional connectivity patterns of human magnetoencephalographic recordings: a 'small-world' network? Neurosci Lett 355: 25-28.
27. Eguíluz VM, Chialvo DR, Cecchi GA, Baliki M, Apkarian AV (2005) Scale-free brain functional networks. Phys Rev Lett 94: 018102.
28. Stam CJ, Jones BF, Nolte G, Breakspear M, Scheltens P (2007) Small-world networks and functional connectivity in Alzheimer's disease. Cereb Cortex 17: 92-99. (Pubitemid 44973898)
29. Sijben JWC, de Wilde MC, Wieggers R, Groenendijk M, Kamphuis PJGH (2011) A multi nutrient concept to enhance synapse formation and function: science behind a medical food for Alzheimer's disease. OCL 18: 267-270.
30. van Wijk N, Broersen L, de Wilde M, Hageman R, Groenendijk M, et al. (2014) Targeting Synaptic Dysfunction in Alzheimer's Disease by Administering a Specific Nutrient Combination. J Alzheimer's Dis: 459-479.
31. Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, et al. (2006) Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res 1088: 83-92. (Pubitemid 43729416)
32. Pooler AM, Guez DH, Benedictus R, Wurtman RJ (2005) Uridine enhances neurite outgrowth in nerve growth factor-differentiated PC12 [corrected]. Neuroscience 134: 207-214. (Pubitemid 40943647)
33. Sakamoto T, Cansev M, Wurtman RJ (2007) Oral supplementation with docosahexaenoic acid and uridine-59-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 1182: 50-59. (Pubitemid 350086992)
34. van Wijk N, Watkins CJ, Hageman RJJ, Sijben JCW, Kamphuis PGHJ, et al. (2012) Combined dietary folate, vitamin B-12, and vitamin B-6 intake influences plasma docosahexaenoic acid concentration in rats. Nutr Metab (Lond) 9: 49.
35. van Wijk N, Watkins CJ, Böhlke M, Maher TJ, Hageman RJJ, et al. (2012) Plasma choline concentration varies with different dietary levels of vitamins B6, B12 and folic acid in rats maintained on choline-adequate diets. Br J Nutr 107: 1408-1412.
36. Scheltens P, Twisk JWR, Blesa R, Scarpini E, von Arnim CAF, et al. (2012) Efficacy of souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis 31: 225-236.
37. Niedermeyer E, Schomer DL (2011) Niedermeyer's electroencephalography basic principles, clinical applications, and related fields. Philadelphia (Penn.): Wolters Kluwer Health/Lippincott Williams & Wilkins.
38. Stam CJ, de Haan W, Daffertshofer A, Jones BF, Manshanden I, et al. (2009) Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. Brain 132: 213-224.
39. Posner MI, Petersen SE, Fox PT, Raichle ME (1988) Localization of cognitive operations in the human brain. Science 240: 1627-1631.
40. Sanz-Arigita EJ, Schoonheim MM, Damoiseaux JS, Rombouts SARB, Maris E, et al. (2010) Loss of 'small-world' networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity. PLoS One 5: e13788.
41. de Haan W, Pijnenburg YAL, Strijers RLM, van der Made Y, van der Flier WM, et al. (2009) Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory. BMC Neurosci 10: 101.
42. Wang XJ (2010) Neurophysiological and computational principles of cortical rhythms in cognition. Physiol Rev 90: 1195-1268.
43. Engel AK, Fries P (2010) Beta-band oscillations-signalling the status quo? Curr Opin Neurobiol 20: 156-165.
44. Buldú JM, Bajo R, Maestú F, Castellanos N, Leyva I, et al. (2011) Reorganization of functional networks in mild cognitive impairment. PLoS One 6: e19584.
45. Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, et al. (2013) Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12: 207-216.
46. Whitham EM, Pope KJ, Fitzgibbon SP, Lewis T, Clark CR, et al. (2007) Scalp electrical recording during paralysis: quantitative evidence that EEG frequencies above 20 Hz are contaminated by EMG. Clin Neurophysiol 118: 1877-1888. (Pubitemid 47031703)
47. Başar E (2013) A review of gamma oscillations in healthy subjects and in cognitive impairment. Int J Psychophysiol 90: 99-117.
48. Wurtman RJ, Cansev M, Sakamoto T, Ulus IH (2009) Use of phosphatide precursors to promote synaptogenesis. Annu Rev Nutr 29: 59-87.
49. Holguin S, Martinez J, Chow C, Wurtman R (2008) Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J 22: 3938-3946.
50. Savelkoul PJ, Janickova H, Kuipers AA, Hageman RJ, Kamphuis PJ, et al. (2012) A specific multi-nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro. J Neurochem 120: 631-640.
51. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, et al. (2009) Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci 29: 1860-1873.
52. Greicius MD, Srivastava G, Reiss AL, Menon V (2004) Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 101: 4637-4642. (Pubitemid 38437463)
53. de Haan W, van der Flier WM, Koene T, Smits LL, Scheltens P, et al. (2011) Disrupted modular brain dynamics reflect cognitive dysfunction in Alzheimer's disease. Neuroimage.
54. de Haan W, Sporns O, Mott K, van Straaten ECW, Scheltens P, et al. (2012) Activity Dependent Degeneration Explains Hub Vulnerability in Alzheimer's Disease. PLoS Comput Biol 8: e1002582.